KZA kazia therapeutics limited

I agree, only a matter of weeks before OVATURE. If a phase III...

  1. 3,045 Posts.
    I agree, only a matter of weeks before OVATURE. If a phase III trial for a pan-acting cancer agent with an excellent safety profile can't excite the market then nothing will. Have a feeling many investors have just lost interest due to ongoing delays... but if results are positive, then we could be in for a really nice ride.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.